iShares Neuroscience and Healthcare ETF · Other
3m RS is unavailable, Market Stance is 47.8
As of 2026-08-24, iShares Neuroscience and Healthcare ETF (IBRN) has a 3-month relative strength percentile of — within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 47.8 (Neutral). Sector: Other. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
| # | Holding | Weight | Value |
|---|---|---|---|
| 1 | XENE | 4.79% | $248K |
| 2 | AXSM | 4.59% | $238K |
| 3 | ARWR | 4.41% | $228K |
| 4 | ALKS | 4.20% | $217K |
| 5 | CENTESSA PHARMACEUTICALS PLC | 3.95% | $204K |
| 6 | ARGX | 3.88% | $201K |
| 7 | PTCT | 3.69% | $191K |
| 8 | NBIX | 3.68% | $191K |
| 9 | BIIB | 3.67% | $190K |
| 10 | SRRK | 3.67% | $190K |
| 11 | PRAX | 3.66% | $189K |
| 12 | ACAD | 3.61% | $187K |
| 13 | DNTH | 3.39% | $175K |
| 14 | CPRX | 3.29% | $170K |
| 15 | DNLI | 2.82% | $146K |
| 16 | SUPN | 2.78% | $144K |
| 17 | EWTX | 2.53% | $131K |
| 18 | DYN | 2.36% | $122K |
| 19 | AXGN | 2.34% | $121K |
| 20 | SRPT | 2.21% | $114K |
| 21 | SK Biopharmaceuticals Co Ltd | 2.04% | $106K |
| 22 | H. LUNDBECK A/S | 1.92% | $99K |
| 23 | CAPR | 1.75% | $90K |
| 24 | TSHA | 1.53% | $79K |
| 25 | BHVN | 1.30% | $67K |
Showing 25 of 66 holdings.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
Daily range, ATR, beta, and the math for a 1-ADR stop.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IBRN Jan avg: 0.98% median: 1.56% win: 75% σ: 2.72% n: 4 2022-08-29 → 2026-07-31 | IBRN Feb avg: -2.95% median: -3.04% win: 25% σ: 3.32% n: 4 2022-08-29 → 2026-07-31 | IBRN Mar avg: -3.24% median: -2.90% win: 25% σ: 5.49% n: 4 2022-08-29 → 2026-07-31 | IBRN Apr avg: 0.51% median: 2.69% win: 75% σ: 5.82% n: 4 2022-08-29 → 2026-07-31 | IBRN May avg: -0.31% median: -0.97% win: 50% σ: 3.17% n: 4 2022-08-29 → 2026-07-31 | IBRN Jun avg: 2.09% median: 0.16% win: 75% σ: 4.15% n: 4 2022-08-29 → 2026-07-31 | IBRN Jul avg: 2.80% median: 4.02% win: 75% σ: 6.46% n: 4 2022-08-29 → 2026-07-31 | IBRN Aug avg: -0.05% median: -0.40% win: 50% σ: 5.67% n: 4 2022-08-29 → 2026-07-31 (current) | IBRN Sep avg: -0.62% median: -0.36% win: 50% σ: 6.98% n: 4 2022-08-29 → 2026-07-31 | IBRN Oct avg: 3.46% median: 4.41% win: 75% σ: 8.72% n: 4 2022-08-29 → 2026-07-31 | IBRN Nov avg: 5.68% median: 5.24% win: 100% σ: 3.92% n: 4 2022-08-29 → 2026-07-31 | IBRN Dec avg: 3.81% median: -0.32% win: 50% σ: 12.69% n: 4 2022-08-29 → 2026-07-31 |
Holdings of IBRN currently on TickerStance stock-RS leaderboards.
Metrics matched 54 tickers across 66 holdings rows (79.8% of fund weight). Metrics as of 2026-08-24; holdings from the filing.